Gerard Brophy, EVP, Biopharma Production at Avantor, Inc. (AVTR), sold 148,454 shares at $38.65 ($6.0M) on 2022-01-05, disclosed to the SEC on 2022-01-05.
Open-market sale of $6.0M AVTR by EVP, Biopharma Production. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.14 | 6,516 | $275K | 4.6% |
| 2 | $40.77 | 59,418 | $2.4M | 40.3% |
| 3 | $40.77 | 59,418 | $2.4M | 40.3% |
| 4 | $38.65 | 11,551 | $446K | 7.4% |
| 5 | $38.65 | 11,551 | $446K | 7.4% |
| Total | $40.50 avg | 148,454 |
| $6.0M |
| 100% |
| Filing → |
| AVTR | SELL | 2023-02-02 | $568K | — | Filing → |
| AVTR | SELL | 2022-05-23 | $1.2M | — | Filing → |
| AVTR | SELL | 2022-03-02 | $140K | — | Filing → |